Back to CVE records
Medium 6.5Published Oct 6, 2026

CVE-2026-106489Backstage: Improper authorization enforcement for TechDocs static content

Updated under an hour ago ()

Does this affect you?

It affects backstage and 1 other product. Add what you run to find out whether that includes you.

No exploitation reported and no EPSS estimate yet.

Backstage is an open framework for building developer portals. Prior to 2.2.4, the @backstage/plugin-techdocs-backend package is affected by improper authorization enforcement for techdocs static content. An authenticated user with access to one TechDocs documentation site could craft a URL able to read documentation belonging to a different entity. This only affects deployments using the external TechDocs builder with an external storage provider (S3, GCS, etc.) and the permission framework enabled. Instances that do not use the permission framework are unaffected, since TechDocs content is visible to all authenticated users by design. This issue is fixed in version 2.2.4.

CVSS
6.5 MEDIUM (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N
Weakness (CWE)
CWE-22, CWE-862
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
Not loaded for this CVE
Assigned by
GitHub_M
NVD analysis
Undergoing Analysis
Record last updated
Oct 7, 2026
First seen by InfoSec Signals
Oct 9, 2026

Affected products

Affected products
backstage backstage
backstage:backstage (from the name)
before 1.54.6
CNA record
@backstage plugin-techdocs-backend
backstage:plugin_techdocs_backend (from the name)
before 2.2.4
CNA record

References

  • x-refsource-confirm
  • x-refsource-misc
  • x-refsource-misc

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.